|
G
|
CSF3
|
colony stimulating factor 3
|
treatment
|
ISO
|
associated with Multiple Myeloma; associated with Graves Disease;
|
RGD |
PMID:8935143 PMID:15785251 |
RGD:11039034 RGD:11039041 |
NCBI chr16:66,162,814...66,166,192
Ensembl chr16:66,163,681...66,165,172
|
|
G
|
IL1B
|
interleukin 1 beta
|
treatment
|
ISO
|
associated with Glioblastoma;
|
RGD |
PMID:1331350 |
RGD:10450883 |
NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
|
|
G
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
ISO
|
associated with Leukemia;protein:decreased expression:serum:
|
RGD |
PMID:8698137 |
RGD:11528539 |
NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
|
|
G
|
LOC103215403
|
arylamine N-acetyltransferase 2
|
|
ISO
|
associated with Inflammation;
|
RGD |
PMID:10739170 |
RGD:11532771 |
NCBI chr 8:16,451,144...16,494,961
Ensembl chr 8:16,493,749...16,494,621
|
|
|
G
|
CYP3A5
|
cytochrome P450 family 3 subfamily A member 5
|
susceptibility
|
ISO
|
associated with breast neoplasm;DNA:polymorphism:splice junction:6986A>G (human)
|
RGD |
PMID:19332043 |
RGD:11353804 |
NCBI chr28:13,473,649...13,517,905
Ensembl chr28:13,491,483...13,519,507
|
|
G
|
GSTP1
|
glutathione S-transferase pi 1
|
susceptibility
|
ISO
|
DNA:polymorphism: : rs1695(human)
|
RGD |
PMID:25008867 |
RGD:10755412 |
NCBI chr 1:6,676,897...6,679,936
|
|
G
|
ITPA
|
inosine triphosphatase
|
|
ISO
|
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:SNP: :rs41320251 (human)
|
RGD |
PMID:18685564 |
RGD:10766478 |
NCBI chr 2:33,873,231...33,893,329
Ensembl chr 2:33,873,339...33,893,556
|
|
G
|
LOC103223675
|
low affinity immunoglobulin gamma Fc region receptor III-A
|
treatment
|
ISO
|
associated with Lymphoma, Large B-Cell, Diffuse;DNA:SNP: :rs396991 (human)
|
RGD |
PMID:27282998 |
RGD:11344967 |
NCBI chr20:2,466,492...2,475,579
|
|
G
|
MBL2
|
mannose binding lectin 2
|
susceptibility disease progression
|
ISO
|
associated with leukemia; associated with Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphisms:exon: associated with Neoplasms;DNA:SNP,haplotyep:promoter:
|
RGD |
PMID:20930093 PMID:24453114 PMID:24819208 |
RGD:11530041 RGD:11530043 RGD:11530056 |
NCBI chr 9:78,389,534...78,394,753
Ensembl chr 9:78,389,947...78,396,079
|
|
G
|
MDM2
|
MDM2 proto-oncogene
|
susceptibility
|
ISO
|
associated with Breast Neoplasms;DNA:SNP:cds:309T>G(rs2279744)(human)
|
RGD |
PMID:21706156 |
RGD:11073725 |
NCBI chr11:64,434,203...64,465,490
Ensembl chr11:64,434,261...64,469,890
|
|
G
|
TP53
|
tumor protein p53
|
susceptibility
|
ISO
|
associated with Breast Neoplasms;DNA:SNP:cds: p.R72P(rs1042522)(human)
|
RGD |
PMID:21706156 |
RGD:11073725 |
NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223
|
|
|
G
|
ABCB1
|
ATP binding cassette subfamily B member 1
|
susceptibility
|
ISO
|
Breast Neoplasms;DNA:SNP: :3435 C>T(human) associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:SNPs:rs1045642,rs1128503(human) associated with Carcinoma, Non-Small-Cell Lung;DNA:SNP: :2677G>T(human)
|
RGD |
PMID:17534875 PMID:22271208 PMID:25007187 |
RGD:11080964 RGD:11080979 RGD:11081001 |
NCBI chr21:61,211,044...61,430,691
Ensembl chr21:61,322,748...61,529,274
|
|
G
|
ABCC2
|
ATP binding cassette subfamily C member 2
|
susceptibility no_association
|
ISO
|
associated with neoplasm;DNA:SNP:rs12762549(human)
|
RGD |
PMID:18294295 PMID:23188068 |
RGD:11080980 RGD:11080999 |
NCBI chr 9:92,826,423...92,902,389
Ensembl chr 9:92,841,818...92,902,265
|
|
G
|
CSF3
|
colony stimulating factor 3
|
treatment
|
ISO
|
associated with Hepatitis C, Chronic; associated with Leukemia, Hairy Cell;
|
RGD |
PMID:2461131 PMID:17660602 |
RGD:11039035 RGD:11039036 |
NCBI chr16:66,162,814...66,166,192
Ensembl chr16:66,163,681...66,165,172
|
|
G
|
CYP2C8
|
cytochrome P450 family 2 subfamily C member 8
|
susceptibility
|
ISO
|
associated with Ovarian Neoplasms: DNA:polymorphism: :
|
RGD |
PMID:21702053 |
RGD:11353800 |
NCBI chr 9:88,154,131...88,183,915
Ensembl chr 9:88,154,134...88,183,458
|
|
G
|
CYP3A5
|
cytochrome P450 family 3 subfamily A member 5
|
susceptibility
|
ISO
|
associated with breast neoplasm;DNA:polymorphism:splice junction:6986A>G (human) associated with Ovarian Neoplasms: DNA:polymorphism: :
|
RGD |
PMID:19332043 PMID:21702053 |
RGD:11353800 RGD:11353804 |
NCBI chr28:13,473,649...13,517,905
Ensembl chr28:13,491,483...13,519,507
|
|
G
|
DPYD
|
dihydropyrimidine dehydrogenase
|
treatment no_association
|
ISO
|
DNA:splice-site mutation, missense mutations: :multiple associated with Neoplasms;DNA:missense mutations: :multiple associated with Colorectal Neoplasms;DNA:SNPs: :rs1801159 (1896T>C), rs17376848 (human) associated with Neoplasms;DNA:missense mutation: :p.M166V (496A>G) (human) associated with Neoplasms;DNA:splice-site mutation:intron:IVS14+1G>A (human)
|
RGD |
PMID:11156223 PMID:12209976 PMID:19473056 PMID:23942539 |
RGD:11098817 RGD:11251736 RGD:11251737 RGD:11251738 |
NCBI chr20:35,376,738...36,215,388
Ensembl chr20:35,377,266...36,215,679
|
|
G
|
ERCC1
|
ERCC excision repair 1, endonuclease non-catalytic subunit
|
treatment
|
ISO
|
associated with Colorectal Neoplasms;DNA:SNP
|
RGD |
PMID:23543295 |
RGD:11340199 |
NCBI chr 6:38,857,067...38,900,177
Ensembl chr 6:38,854,803...38,872,967
|
|
G
|
ERCC2
|
ERCC excision repair 2, TFIIH core complex helicase subunit
|
treatment
|
ISO
|
associated with Urinary Bladder Neoplasms;DNA:SNP: :p.K751Q (rs13181) (human)
|
RGD |
PMID:21047201 |
RGD:11098572 |
NCBI chr 6:38,804,296...38,823,229
Ensembl chr 6:38,801,423...38,823,073
|
|
G
|
GSTP1
|
glutathione S-transferase pi 1
|
susceptibility
|
ISO
|
DNA:SNP:cds:p.I105V (rs1695) (human)
|
RGD |
PMID:23812950 |
RGD:10755330 |
NCBI chr 1:6,676,897...6,679,936
|
|
G
|
IL1A
|
interleukin 1 alpha
|
treatment
|
ISO
|
associated with Carcinoma, Non-Small-Cell Lung
|
RGD |
PMID:7666093 |
RGD:11051963 |
NCBI chr14:15,789,710...15,801,938
Ensembl chr14:15,789,013...15,796,611
|
|
G
|
LOC103223675
|
low affinity immunoglobulin gamma Fc region receptor III-A
|
|
ISO
|
associated with Lymphoma, B-Cell;DNA:polymorphism: :p.V158F (human) associated with Non-Hodgkin lymphoma;DNA:polymorphism: :p.V158F (human) associated with Lymphoma, Large B-Cell, Diffuse;DNA:polymorphism: :p.V158F (human)
|
RGD |
PMID:19933905 PMID:20730791 PMID:21883784 |
RGD:11344964 RGD:11344973 RGD:11352256 |
NCBI chr20:2,466,492...2,475,579
|
|
G
|
MDM2
|
MDM2 proto-oncogene
|
susceptibility
|
ISO
|
associated with Small Cell Lung Carcinoma;DNA:SNP::rs2279744(human)
|
RGD |
PMID:24732641 |
RGD:11073715 |
NCBI chr11:64,434,203...64,465,490
Ensembl chr11:64,434,261...64,469,890
|
|
G
|
SLCO1B3
|
solute carrier organic anion transporter family member 1B3
|
susceptibility no_association
|
ISO
|
associated with neoplasm;DNA:SNP:rs11045585(human) associated with neoplasm;DNA:SNP: rs11045585(human)
|
RGD |
PMID:18294295 PMID:23188068 |
RGD:11080980 RGD:11080999 |
NCBI chr11:20,637,429...20,760,577
Ensembl chr11:20,648,582...20,761,161
|
|
G
|
SOD2
|
superoxide dismutase 2
|
susceptibility
|
ISO
|
associated with female breast cancer;DNA:missense mutation:cds:p.V16A (rs4880) (human)
|
RGD |
PMID:20309628 |
RGD:11035278 |
NCBI chr13:87,284,537...87,297,998
Ensembl chr13:87,280,686...87,297,974
|
|
G
|
TP53
|
tumor protein p53
|
susceptibility
|
ISO
|
associated with Small Cell Lung Carcinoma;DNA:SNP:: rs1042522(human)
|
RGD |
PMID:24732641 |
RGD:11073715 |
NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223
|
|